Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alfasino is a specialized provider of pharmaceutical raw materials, active pharmaceutical ingredients (APIs), and chemical intermediates based in China. Established in 2000, the company serves as a strategic sourcing partner for global life science organizations, offering services in custom synthesis, quality assurance, and regulatory affairs. Alfasino facilitates the procurement of high-quality chemicals by bridging Chinese manufacturing capabilities with international regulatory standards such as GMP and ISO. Their product portfolio supports drug development from laboratory scale to commercial production across various therapeutic areas. The company also provides essential documentation support, including Drug Master Files and Certificates of Suitability, to assist clients with global regulatory filings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alfasino.